Texte intégral
N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
NOVARTIS PHARMACEUTICALS CORPORATION,
Plaintiff-Appellant
v.
TORRENT PHARMA INC., TORRENT
PHARMACEUTICALS LTD.,
Defendants-Appellees
______________________
2023-2219
______________________
Appeal from the United States District Court for the
District of Delaware in No. 1:19-cv-01979-RGA, Judge
Richard G. Andrews.
______________________
O R D E R
Upon consideration of the parties’ joint stipulation of
voluntary dismissal of this appeal, pursuant to Federal
Rule of Appellate Procedure 42(b)(1), ECF No. 18,
I T I S O RDERED T HAT :
(1) The appeal is voluntarily dismissed.
Case: 23-2219 Document: 19 Page: 1 Filed: 09/03/2024
-- 1 of 2 --
NOVARTIS PHARMACEUTICALS CORPORATION v. TORRENT
PHARMA INC.
2
(2) Each side shall bear its own costs.
September 3, 2024
Date
F OR THE COURT
ISSUED AS A MANDATE: September 3, 2024
Case: 23-2219 Document: 19 Page: 2 Filed: 09/03/2024
-- 2 of 2 --